JPWO2023102463A5 - - Google Patents
Info
- Publication number
- JPWO2023102463A5 JPWO2023102463A5 JP2024532776A JP2024532776A JPWO2023102463A5 JP WO2023102463 A5 JPWO2023102463 A5 JP WO2023102463A5 JP 2024532776 A JP2024532776 A JP 2024532776A JP 2024532776 A JP2024532776 A JP 2024532776A JP WO2023102463 A5 JPWO2023102463 A5 JP WO2023102463A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- amino acid
- subject
- seq
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284978P | 2021-12-01 | 2021-12-01 | |
| US63/284,978 | 2021-12-01 | ||
| US202263348201P | 2022-06-02 | 2022-06-02 | |
| US63/348,201 | 2022-06-02 | ||
| PCT/US2022/080728 WO2023102463A1 (en) | 2021-12-01 | 2022-12-01 | Methods of using interleukin-2 agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024543209A JP2024543209A (ja) | 2024-11-19 |
| JP2024543209A5 JP2024543209A5 (https=) | 2025-12-08 |
| JPWO2023102463A5 true JPWO2023102463A5 (https=) | 2025-12-08 |
Family
ID=84981477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532776A Pending JP2024543209A (ja) | 2021-12-01 | 2022-12-01 | インターロイキン－２剤の使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240041981A1 (https=) |
| EP (1) | EP4440598A1 (https=) |
| JP (1) | JP2024543209A (https=) |
| KR (1) | KR20250169356A (https=) |
| CN (1) | CN120131911A (https=) |
| AU (1) | AU2022399832A1 (https=) |
| CA (1) | CA3238574A1 (https=) |
| MX (1) | MX2024006746A (https=) |
| TW (1) | TW202333772A (https=) |
| WO (1) | WO2023102463A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3147757A1 (en) | 2019-07-26 | 2021-02-04 | Visterra, Inc. | Interleukin-2 agents and uses thereof |
| EP4255466A1 (en) | 2020-12-04 | 2023-10-11 | Visterra, Inc. | Methods of using interleukin-2 agents |
| WO2025221954A1 (en) * | 2024-04-17 | 2025-10-23 | Visterra, Inc. | Use of il-2 variant for treating kidney transplant rejection |
| CN119638850A (zh) * | 2024-11-07 | 2025-03-18 | 浙江大学 | 双特异性细胞因子融合蛋白及其应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| EP0436597B1 (en) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8905669D0 (en) | 1989-03-13 | 1989-04-26 | Celltech Ltd | Modified antibodies |
| WO1991000906A1 (en) | 1989-07-12 | 1991-01-24 | Genetics Institute, Inc. | Chimeric and transgenic animals capable of producing human antibodies |
| EP1690934A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| EP0585287B1 (en) | 1990-07-10 | 1999-10-13 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ATE352612T1 (de) | 1990-08-29 | 2007-02-15 | Pharming Intellectual Pty Bv | Homologe rekombination in säugetier-zellen |
| ATE300615T1 (de) | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
| CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
| EP0575485A1 (en) | 1991-03-01 | 1993-12-29 | Dyax Corp. | Process for the development of binding mini-proteins |
| DK0580737T3 (da) | 1991-04-10 | 2004-11-01 | Scripps Research Inst | Heterodimere receptorbiblioteker ved anvendelse af phagemider |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| AU701578B2 (en) | 1992-08-21 | 1999-02-04 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| US6955807B1 (en) * | 1998-05-15 | 2005-10-18 | Bayer Pharmaceuticals Corporation | IL-2 selective agonists and antagonists |
| IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
| US9580486B2 (en) * | 2013-03-14 | 2017-02-28 | Amgen Inc. | Interleukin-2 muteins for the expansion of T-regulatory cells |
| PH12017501856B1 (en) * | 2015-04-10 | 2022-08-10 | Amgen Inc | Interleukin-2 muteins for the expansion of t-regulatory cells |
| KR102687530B1 (ko) | 2016-05-04 | 2024-07-25 | 암젠 인크 | T-조절 세포의 증식을 위한 인터류킨-2 뮤테인 |
| SG11201900616UA (en) | 2016-08-02 | 2019-02-27 | Visterra Inc | Engineered polypeptides and uses thereof |
| US20210017247A1 (en) * | 2017-07-03 | 2021-01-21 | Torque Therapeutics, Inc. | Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof |
| CA3147757A1 (en) | 2019-07-26 | 2021-02-04 | Visterra, Inc. | Interleukin-2 agents and uses thereof |
-
2022
- 2022-12-01 WO PCT/US2022/080728 patent/WO2023102463A1/en not_active Ceased
- 2022-12-01 CN CN202510086918.0A patent/CN120131911A/zh active Pending
- 2022-12-01 EP EP22843966.7A patent/EP4440598A1/en active Pending
- 2022-12-01 JP JP2024532776A patent/JP2024543209A/ja active Pending
- 2022-12-01 US US18/060,725 patent/US20240041981A1/en active Pending
- 2022-12-01 CA CA3238574A patent/CA3238574A1/en active Pending
- 2022-12-01 KR KR1020247021478A patent/KR20250169356A/ko active Pending
- 2022-12-01 AU AU2022399832A patent/AU2022399832A1/en active Pending
- 2022-12-01 MX MX2024006746A patent/MX2024006746A/es unknown
- 2022-12-01 TW TW111146169A patent/TW202333772A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6084215B2 (ja) | ポリエチレングリコールまたはその誘導体でｐｅｇ化されたエキセンジン−４類似体、その調製法、および活性成分としてこれを含有する、糖尿病を予防または処置するための薬学的組成物 | |
| CA2122340C (en) | Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs | |
| JP2019194251A5 (https=) | ||
| DE69734766T2 (de) | Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen | |
| CN102718858B (zh) | 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用 | |
| JP2017225444A5 (https=) | ||
| JP2019507589A5 (https=) | ||
| Al Musaimi | FDA's stamp of approval: Unveiling peptide breakthroughs in cardiovascular diseases, ACE, HIV, CNS, and beyond | |
| JPWO2019156137A5 (https=) | ||
| JPH02500517A (ja) | ペプチド化合物 | |
| JP2018502860A5 (https=) | ||
| JPWO2021021606A5 (https=) | ||
| JPWO2023102463A5 (https=) | ||
| TW202104274A (zh) | 用於治療ｈｉｖ感染之三特異性及／或三價結合蛋白 | |
| JP2023547405A (ja) | Ｃａｓ９－ＲＮＰ及び他の核タンパク質カーゴの形質導入のために適合された最小長のシャトル剤ペプチド及びそのバリアント | |
| TW434261B (en) | Motilin-like polypeptides with gastrointestinal motor stimulating activity | |
| US9738884B2 (en) | Therapeutic agent for epithelial and endothelial injury | |
| JPH02152989A (ja) | 抗ｈｉｖペプチド | |
| JPH11501283A (ja) | Ｉ型インターフェロンに対する中和活性を有する、インターフェロンレセプターに対するモノクローナル抗体を含んでなる医薬組成物 | |
| JPWO2022120224A5 (https=) | ||
| JPWO2021229076A5 (https=) | ||
| JP2973621B2 (ja) | 新規なトキソプラズマ増殖抑制剤 | |
| JP2995860B2 (ja) | 新規ペプチド | |
| JP3024311B2 (ja) | Ｉｌ−２受容体重鎖に結合するポリペプチド | |
| JPWO2020178638A5 (https=) |